Your position:
www.healthoo.com
>>
EN
>>
EN
>>
Pharmaceutical News
>>
Taizhou Haisheng Pharmaceutical Co., Ltd. invested RMB 1.5 billion to start the project of high-end APIs preparations (ergosterol, vitamin D2 other products).
>> article
Taizhou Haisheng Pharmaceutical Co., Ltd. invested RMB 1.5 billion to start the project of high-end APIs preparations (ergosterol, vitamin D2 other products).
Editor:xuezhe Clicks:
0
Date:2022-7-1 16:13:38
Keyword:
vitamin D2
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
NHU Heilongjiang Vitamin C production line began to stop production ma...
The domestic price of vitamin C raw materials bottomed out, the export...
The vitamin B2 production line of Guangji Pharmaceutical (Mengzhou) Co...
In the summer of 2022, vitamin C enterprises have successively stopped...
The vitamin K3 production line of Mianyang Wainida Chemical Co., Ltd. ...
Garden Biological Co., Ltd. has basically completed the whole industry...
Brothers vitamin K3 production line is scheduled to stop production fo...
Vitamin B1 (nitrate)reference price
Vitamin B1 (hydrochloride)reference price
Vitamin B2 (feed) reference price
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
